©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 110202
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110202
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110202
Table 1 Expression of KLK10 in some types of cancers
| Cancer | Expression of KLK10 in the tumor compared with non-tumor conditions | Ref. |
| Breast cancer | Expression depends on stage, grade, and metastasis | [37,44,46-48] |
| Gastric cancer | Expression depends on stage, grade, and metastasis | [42,49,94] |
| Prostate cancer | Decreased | [37,38] |
| Esophageal cancer | Decreased | [52] |
| Acute lymphoblastic leukemia | Decreased | [40,41] |
| Testicular cancer | Decreased | [95] |
| Ovarian cancer | Decreased | [37] |
| Cutaneous melanoma | Increased | [55] |
| Colorectal cancer | Increased | [50,51] |
| Colon cancer | Increased | [96] |
| Pancreatic cancer | Increased | [53,54] |
- Citation: Palacios Serrato EG, Medina-Abreu KH, Oropeza-Martínez E, Jacinto-Alemán LF, Macías-Silva M, Tecalco-Cruz AC. ADAMTS-8 and kallikrein-related peptidases 10 and 5 proteases also have a tumor suppression role. World J Clin Oncol 2025; 16(11): 110202
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/110202.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.110202